We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Fibrinogen-Albumin Ratio Correlated to Ankylosing Spondylitis Disease Activity

By LabMedica International staff writers
Posted on 23 Mar 2020
Print article
Image: Sacroiliac joint biopsy specimen of a 29 year old male patient with ankylosing spondylitis. The biopsy specimen shows a subchondral cellular infiltrate partly invading the cartilage. Fibroblasts and activated lymphocytes are seen in the infiltrate. In between are areas of calcification and bone formation (Photo courtesy of Professor J. Braun).
Image: Sacroiliac joint biopsy specimen of a 29 year old male patient with ankylosing spondylitis. The biopsy specimen shows a subchondral cellular infiltrate partly invading the cartilage. Fibroblasts and activated lymphocytes are seen in the infiltrate. In between are areas of calcification and bone formation (Photo courtesy of Professor J. Braun).
Ankylosing spondylitis (AS) is a systematic inflammatory autoimmune disease that primarily involves the spine and sacroiliac joints. Typically the joints where the spine joins the pelvis are also affected and occasionally other joints such as the shoulders or hips are involved. Back pain is a characteristic symptom of AS, and it often comes and goes.

Some simple and cost-effective inflammatory indicators for AS, such as neutrophils to lymphocytes ratio (NLR), platelets to lymphocytes ratio (PLR) and monocytes to lymphocytes ratio (MLR) have been explored. Fibrinogen (Fib) is a critical factor involved in the coagulation system, which has been reported to be increased in AS patients compared with controls and significantly correlated with C-reactive protein (CRP).

Rheumatologists and Immunologists at the Guangdong Second Provincial General Hospital (Guangzhou, China) performed a retrospective study that included 135 AS patients that visited from March 2016 and June 2019. Seventy-six age- and sex-matched healthy subjects from the Department of Physical Examination Center who had no evidence of illness were enrolled in the control group at the same period.

Clinical characteristics included human leukocyte antigen (HLA)-B27 status, number of white blood cells (WBCs), lymphocytes, neutrophils, monocytes, platelets (PLT), red blood cell distribution width (RDW), Fib, albumin (ALB), globulin (GLB), CRP and erythrocyte sedimentation rate (ESR) level were collected. neutrophil to lymphocyte ratio (NLR), monocyte to lymphocytes ratio (MLR), platelet-lymphocyte ratio (PLR) and fibrinogen to albumin ratio (FAR) were calculated. All the peripheral venous blood samples were taken after an overnight fast of at least eight hours.

The investigators reported that AS patients showed higher FAR levels than the controls. FAR was also increased in active group of AS patients than those in inactive group. Spearman analyses showed that FAR was positively related with Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in AS patients. ROC curve analyses revealed that the AUC of FAR was higher than ALB and Fib. In addition, the optimal cutoff value of FAR for AS diagnosis was 78.84, with a specificity of 88.2% and sensitivity of 77.0%. Logistical regression analyses showed that FAR (odds ratio = 13.091) was a predictor for AS disease activity.

The authors concludes that their study showed that FAR was increased in AS patients and significantly positively correlated with AS disease activity. High FAR was revealed as an adverse predictor for the disease activity in AS patients. The study indicated that FAR may be a novel biomarker for reflecting disease activity in AS patients. The study was published on February 26, 2020 in the journal Clinica Chimica Acta.

Related Links:
Guangdong Second Provincial General Hospital

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more